Expleo Solutions Limited (BSE: EXPLEOSOL.BO) Stock Competitors & Peer Comparison
See EXPLEOSOL.BO's competitors and their performance on the BSE and across the wider stock market.
Peer Comparison Table: Information Technology Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for EXPLEOSOL.BO and its BSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EXPLEOSOL.BO | ₹801.85 | -13.54% | 14.1B | 11.59 | ₹78.32 | N/A |
| TCS.NS | ₹2,365.60 | -3.31% | 8.8T | 16.69 | ₹145.73 | +4.56% |
| TCS.BO | ₹2,365.60 | -3.27% | 8.8T | 16.52 | ₹147.23 | +4.56% |
| INFY.BO | ₹1,130.00 | -2.21% | 4.7T | 16.15 | ₹71.59 | +4.16% |
| INFY.NS | ₹1,130.10 | -2.21% | 4.7T | 16.09 | ₹71.79 | +4.16% |
| HCLTECH.NS | ₹1,346.90 | +0.19% | 3.7T | 20.17 | ₹67.08 | +4.44% |
| HCLTECH.BO | ₹1,346.50 | +0.22% | 3.7T | 20.20 | ₹67.00 | +4.44% |
| WIPRO.BO | ₹183.60 | +0.03% | 1.8T | 14.56 | ₹12.80 | +1.07% |
| WIPRO.NS | ₹183.65 | +0.02% | 1.8T | 14.58 | ₹12.78 | +1.07% |
| TECHM.NS | ₹1,651.30 | +0.43% | 1.6T | 30.73 | ₹54.31 | +3.06% |
Stock Comparison
Tata Consultancy Services Limited (NSE: TCS.NS)
EXPLEOSOL.BO vs TCS.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, TCS.NS has a market cap of 8.8T. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while TCS.NS trades at ₹2,365.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas TCS.NS's P/E ratio is 16.69. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to TCS.NS's ROE of +0.46%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to TCS.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check TCS.NS's competition here
Tata Consultancy Services Limited (BSE: TCS.BO)
EXPLEOSOL.BO vs TCS.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, TCS.BO has a market cap of 8.8T. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while TCS.BO trades at ₹2,365.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas TCS.BO's P/E ratio is 16.52. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to TCS.BO's ROE of +0.46%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to TCS.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check TCS.BO's competition here
Infosys Limited (BSE: INFY.BO)
EXPLEOSOL.BO vs INFY.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, INFY.BO has a market cap of 4.7T. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while INFY.BO trades at ₹1,130.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas INFY.BO's P/E ratio is 16.15. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to INFY.BO's ROE of +0.33%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to INFY.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check INFY.BO's competition here
Infosys Limited (NSE: INFY.NS)
EXPLEOSOL.BO vs INFY.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, INFY.NS has a market cap of 4.7T. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while INFY.NS trades at ₹1,130.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas INFY.NS's P/E ratio is 16.09. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to INFY.NS's ROE of +0.33%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to INFY.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check INFY.NS's competition here
HCL Technologies Limited (NSE: HCLTECH.NS)
EXPLEOSOL.BO vs HCLTECH.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, HCLTECH.NS has a market cap of 3.7T. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while HCLTECH.NS trades at ₹1,346.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas HCLTECH.NS's P/E ratio is 20.17. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to HCLTECH.NS's ROE of +0.24%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to HCLTECH.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check HCLTECH.NS's competition here
HCL Technologies Limited (BSE: HCLTECH.BO)
EXPLEOSOL.BO vs HCLTECH.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, HCLTECH.BO has a market cap of 3.7T. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while HCLTECH.BO trades at ₹1,346.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas HCLTECH.BO's P/E ratio is 20.20. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to HCLTECH.BO's ROE of +0.24%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to HCLTECH.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check HCLTECH.BO's competition here
Wipro Limited (BSE: WIPRO.BO)
EXPLEOSOL.BO vs WIPRO.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, WIPRO.BO has a market cap of 1.8T. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while WIPRO.BO trades at ₹183.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas WIPRO.BO's P/E ratio is 14.56. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to WIPRO.BO's ROE of +0.16%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to WIPRO.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check WIPRO.BO's competition here
Wipro Limited (NSE: WIPRO.NS)
EXPLEOSOL.BO vs WIPRO.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, WIPRO.NS has a market cap of 1.8T. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while WIPRO.NS trades at ₹183.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas WIPRO.NS's P/E ratio is 14.58. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to WIPRO.NS's ROE of +0.16%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to WIPRO.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check WIPRO.NS's competition here
Tech Mahindra Limited (NSE: TECHM.NS)
EXPLEOSOL.BO vs TECHM.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, TECHM.NS has a market cap of 1.6T. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while TECHM.NS trades at ₹1,651.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas TECHM.NS's P/E ratio is 30.73. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to TECHM.NS's ROE of +0.18%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to TECHM.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check TECHM.NS's competition here
Tech Mahindra Limited (BSE: TECHM.BO)
EXPLEOSOL.BO vs TECHM.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, TECHM.BO has a market cap of 1.6T. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while TECHM.BO trades at ₹1,651.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas TECHM.BO's P/E ratio is 30.81. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to TECHM.BO's ROE of +0.18%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to TECHM.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check TECHM.BO's competition here
LTIMindtree Limited (NSE: LTIM.NS)
EXPLEOSOL.BO vs LTIM.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, LTIM.NS has a market cap of 1.3T. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while LTIM.NS trades at ₹4,535.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas LTIM.NS's P/E ratio is 28.28. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to LTIM.NS's ROE of +0.21%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to LTIM.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check LTIM.NS's competition here
LTM Limited (BSE: LTIM.BO)
EXPLEOSOL.BO vs LTIM.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, LTIM.BO has a market cap of 1.3T. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while LTIM.BO trades at ₹4,340.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas LTIM.BO's P/E ratio is 27.74. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to LTIM.BO's ROE of +0.22%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to LTIM.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check LTIM.BO's competition here
LTM Limited (NSE: LTM.NS)
EXPLEOSOL.BO vs LTM.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, LTM.NS has a market cap of 1.3T. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while LTM.NS trades at ₹4,362.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas LTM.NS's P/E ratio is 25.19. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to LTM.NS's ROE of +0.22%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to LTM.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check LTM.NS's competition here
Persistent Systems Limited (BSE: PERSISTENT.BO)
EXPLEOSOL.BO vs PERSISTENT.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, PERSISTENT.BO has a market cap of 862.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while PERSISTENT.BO trades at ₹5,549.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas PERSISTENT.BO's P/E ratio is 44.69. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to PERSISTENT.BO's ROE of +0.25%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to PERSISTENT.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check PERSISTENT.BO's competition here
Persistent Systems Limited (NSE: PERSISTENT.NS)
EXPLEOSOL.BO vs PERSISTENT.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, PERSISTENT.NS has a market cap of 861.6B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while PERSISTENT.NS trades at ₹5,549.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas PERSISTENT.NS's P/E ratio is 44.83. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to PERSISTENT.NS's ROE of +0.25%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to PERSISTENT.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check PERSISTENT.NS's competition here
Coforge Limited (NSE: COFORGE.NS)
EXPLEOSOL.BO vs COFORGE.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, COFORGE.NS has a market cap of 622.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while COFORGE.NS trades at ₹1,721.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas COFORGE.NS's P/E ratio is 38.16. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to COFORGE.NS's ROE of +0.15%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to COFORGE.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check COFORGE.NS's competition here
Coforge Limited (BSE: COFORGE.BO)
EXPLEOSOL.BO vs COFORGE.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, COFORGE.BO has a market cap of 622.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while COFORGE.BO trades at ₹1,720.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas COFORGE.BO's P/E ratio is 38.14. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to COFORGE.BO's ROE of +0.15%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to COFORGE.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check COFORGE.BO's competition here
Mphasis Limited (NSE: MPHASIS.NS)
EXPLEOSOL.BO vs MPHASIS.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, MPHASIS.NS has a market cap of 447.8B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while MPHASIS.NS trades at ₹2,342.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas MPHASIS.NS's P/E ratio is 23.99. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to MPHASIS.NS's ROE of +0.19%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to MPHASIS.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check MPHASIS.NS's competition here
Mphasis Limited (BSE: MPHASIS.BO)
EXPLEOSOL.BO vs MPHASIS.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, MPHASIS.BO has a market cap of 447.5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while MPHASIS.BO trades at ₹2,342.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas MPHASIS.BO's P/E ratio is 24.04. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to MPHASIS.BO's ROE of +0.19%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to MPHASIS.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check MPHASIS.BO's competition here
L&T Technology Services Limited (NSE: LTTS.NS)
EXPLEOSOL.BO vs LTTS.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, LTTS.NS has a market cap of 377.5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while LTTS.NS trades at ₹3,555.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas LTTS.NS's P/E ratio is 28.27. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to LTTS.NS's ROE of +0.21%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to LTTS.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check LTTS.NS's competition here
L&T Technology Services Limited (BSE: LTTS.BO)
EXPLEOSOL.BO vs LTTS.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, LTTS.BO has a market cap of 377.5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while LTTS.BO trades at ₹3,556.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas LTTS.BO's P/E ratio is 28.32. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to LTTS.BO's ROE of +0.21%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to LTTS.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check LTTS.BO's competition here
Hexaware Technologies Ltd (NSE: HEXT.NS)
EXPLEOSOL.BO vs HEXT.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, HEXT.NS has a market cap of 350.8B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while HEXT.NS trades at ₹561.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas HEXT.NS's P/E ratio is 25.35. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to HEXT.NS's ROE of +0.21%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to HEXT.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check HEXT.NS's competition here
Tata Technologies Limited (NSE: TATATECH.NS)
EXPLEOSOL.BO vs TATATECH.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, TATATECH.NS has a market cap of 305.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while TATATECH.NS trades at ₹747.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas TATATECH.NS's P/E ratio is 59.92. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to TATATECH.NS's ROE of +0.15%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to TATATECH.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check TATATECH.NS's competition here
Tata Technologies Limited (BSE: TATATECH.BO)
EXPLEOSOL.BO vs TATATECH.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, TATATECH.BO has a market cap of 304.9B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while TATATECH.BO trades at ₹747.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas TATATECH.BO's P/E ratio is 57.59. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to TATATECH.BO's ROE of +0.15%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to TATATECH.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check TATATECH.BO's competition here
Redington Limited (NSE: REDINGTON.NS)
EXPLEOSOL.BO vs REDINGTON.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, REDINGTON.NS has a market cap of 243.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while REDINGTON.NS trades at ₹321.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas REDINGTON.NS's P/E ratio is 16.30. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to REDINGTON.NS's ROE of +0.18%. Regarding short-term risk, EXPLEOSOL.BO is less volatile compared to REDINGTON.NS. This indicates lower risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check REDINGTON.NS's competition here
Redington Limited (BSE: REDINGTON.BO)
EXPLEOSOL.BO vs REDINGTON.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, REDINGTON.BO has a market cap of 243.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while REDINGTON.BO trades at ₹321.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas REDINGTON.BO's P/E ratio is 16.30. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to REDINGTON.BO's ROE of +0.18%. Regarding short-term risk, EXPLEOSOL.BO is similarly volatile compared to REDINGTON.BO. This indicates similar risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check REDINGTON.BO's competition here
Firstsource Solutions Limited (BSE: FSL.BO)
EXPLEOSOL.BO vs FSL.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, FSL.BO has a market cap of 207B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while FSL.BO trades at ₹302.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas FSL.BO's P/E ratio is 31.48. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to FSL.BO's ROE of +0.15%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to FSL.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check FSL.BO's competition here
Firstsource Solutions Limited (NSE: FSL.NS)
EXPLEOSOL.BO vs FSL.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, FSL.NS has a market cap of 206.9B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while FSL.NS trades at ₹302.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas FSL.NS's P/E ratio is 31.51. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to FSL.NS's ROE of +0.15%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to FSL.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check FSL.NS's competition here
Computer Age Management Services Limited (NSE: CAMS.NS)
EXPLEOSOL.BO vs CAMS.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, CAMS.NS has a market cap of 196.9B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while CAMS.NS trades at ₹796.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas CAMS.NS's P/E ratio is 21.69. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to CAMS.NS's ROE of +0.39%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to CAMS.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check CAMS.NS's competition here
Computer Age Management Services Limited (BSE: CAMS.BO)
EXPLEOSOL.BO vs CAMS.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, CAMS.BO has a market cap of 196.9B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while CAMS.BO trades at ₹796.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas CAMS.BO's P/E ratio is 14.38. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to CAMS.BO's ROE of +0.39%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to CAMS.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check CAMS.BO's competition here
eClerx Services Limited (NSE: ECLERX.NS)
EXPLEOSOL.BO vs ECLERX.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, ECLERX.NS has a market cap of 179.7B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while ECLERX.NS trades at ₹1,845.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas ECLERX.NS's P/E ratio is 25.06. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to ECLERX.NS's ROE of +0.28%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to ECLERX.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check ECLERX.NS's competition here
eClerx Services Limited (BSE: ECLERX.BO)
EXPLEOSOL.BO vs ECLERX.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, ECLERX.BO has a market cap of 179.3B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while ECLERX.BO trades at ₹1,850.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas ECLERX.BO's P/E ratio is 24.99. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to ECLERX.BO's ROE of +0.28%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to ECLERX.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check ECLERX.BO's competition here
KPIT Technologies Limited (NSE: KPITTECH.NS)
EXPLEOSOL.BO vs KPITTECH.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, KPITTECH.NS has a market cap of 160.5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while KPITTECH.NS trades at ₹598.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas KPITTECH.NS's P/E ratio is 25.20. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to KPITTECH.NS's ROE of +0.18%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to KPITTECH.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check KPITTECH.NS's competition here
Hexaware Technologies Limited (NSE: HEXAWARE.NS)
EXPLEOSOL.BO vs HEXAWARE.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, HEXAWARE.NS has a market cap of 141.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while HEXAWARE.NS trades at ₹470.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas HEXAWARE.NS's P/E ratio is 22.98. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to HEXAWARE.NS's ROE of +0.25%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to HEXAWARE.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check HEXAWARE.NS's competition here
Zensar Technologies Limited (BSE: ZENSARTECH.BO)
EXPLEOSOL.BO vs ZENSARTECH.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, ZENSARTECH.BO has a market cap of 118.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while ZENSARTECH.BO trades at ₹508.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas ZENSARTECH.BO's P/E ratio is 15.41. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to ZENSARTECH.BO's ROE of +0.18%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to ZENSARTECH.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check ZENSARTECH.BO's competition here
Zensar Technologies Limited (NSE: ZENSARTECH.NS)
EXPLEOSOL.BO vs ZENSARTECH.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, ZENSARTECH.NS has a market cap of 118.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while ZENSARTECH.NS trades at ₹507.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas ZENSARTECH.NS's P/E ratio is 15.41. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to ZENSARTECH.NS's ROE of +0.18%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to ZENSARTECH.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check ZENSARTECH.NS's competition here
Cyient Limited (NSE: CYIENT.NS)
EXPLEOSOL.BO vs CYIENT.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, CYIENT.NS has a market cap of 93.7B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while CYIENT.NS trades at ₹847.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas CYIENT.NS's P/E ratio is 17.79. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to CYIENT.NS's ROE of +0.07%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to CYIENT.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check CYIENT.NS's competition here
Cyient Limited (BSE: CYIENT.BO)
EXPLEOSOL.BO vs CYIENT.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, CYIENT.BO has a market cap of 93.6B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while CYIENT.BO trades at ₹847.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas CYIENT.BO's P/E ratio is 17.78. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to CYIENT.BO's ROE of +0.07%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to CYIENT.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check CYIENT.BO's competition here
Birlasoft Limited (NSE: BSOFT.NS)
EXPLEOSOL.BO vs BSOFT.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, BSOFT.NS has a market cap of 85.6B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while BSOFT.NS trades at ₹302.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas BSOFT.NS's P/E ratio is 16.47. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to BSOFT.NS's ROE of +0.15%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to BSOFT.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check BSOFT.NS's competition here
Birlasoft Limited (BSE: BSOFT.BO)
EXPLEOSOL.BO vs BSOFT.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, BSOFT.BO has a market cap of 85.6B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while BSOFT.BO trades at ₹302.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas BSOFT.BO's P/E ratio is 16.47. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to BSOFT.BO's ROE of +0.15%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to BSOFT.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check BSOFT.BO's competition here
Sonata Software Limited (NSE: SONATSOFTW.NS)
EXPLEOSOL.BO vs SONATSOFTW.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, SONATSOFTW.NS has a market cap of 85.5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while SONATSOFTW.NS trades at ₹322.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas SONATSOFTW.NS's P/E ratio is 18.12. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to SONATSOFTW.NS's ROE of +0.26%. Regarding short-term risk, EXPLEOSOL.BO is less volatile compared to SONATSOFTW.NS. This indicates lower risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check SONATSOFTW.NS's competition here
Sonata Software Limited (BSE: SONATSOFTW.BO)
EXPLEOSOL.BO vs SONATSOFTW.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, SONATSOFTW.BO has a market cap of 85.5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while SONATSOFTW.BO trades at ₹322.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas SONATSOFTW.BO's P/E ratio is 18.14. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to SONATSOFTW.BO's ROE of +0.26%. Regarding short-term risk, EXPLEOSOL.BO is less volatile compared to SONATSOFTW.BO. This indicates lower risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check SONATSOFTW.BO's competition here
R Systems International Limited (BSE: RSYSTEMINT.BO)
EXPLEOSOL.BO vs RSYSTEMINT.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, RSYSTEMINT.BO has a market cap of 63.6B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while RSYSTEMINT.BO trades at ₹531.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas RSYSTEMINT.BO's P/E ratio is 106.05. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to RSYSTEMINT.BO's ROE of +0.15%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to RSYSTEMINT.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check RSYSTEMINT.BO's competition here
Mastek Limited (BSE: MASTEK.BO)
EXPLEOSOL.BO vs MASTEK.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, MASTEK.BO has a market cap of 60.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while MASTEK.BO trades at ₹1,874.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas MASTEK.BO's P/E ratio is 14.36. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to MASTEK.BO's ROE of +0.15%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to MASTEK.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check MASTEK.BO's competition here
Mastek Limited (NSE: MASTEK.NS)
EXPLEOSOL.BO vs MASTEK.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, MASTEK.NS has a market cap of 59.8B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while MASTEK.NS trades at ₹1,874.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas MASTEK.NS's P/E ratio is 14.36. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to MASTEK.NS's ROE of +0.15%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to MASTEK.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check MASTEK.NS's competition here
Happiest Minds Technologies Limited (NSE: HAPPSTMNDS.NS)
EXPLEOSOL.BO vs HAPPSTMNDS.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, HAPPSTMNDS.NS has a market cap of 57.2B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while HAPPSTMNDS.NS trades at ₹377.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas HAPPSTMNDS.NS's P/E ratio is 27.67. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to HAPPSTMNDS.NS's ROE of +0.13%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to HAPPSTMNDS.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check HAPPSTMNDS.NS's competition here
Happiest Minds Technologies Limited (BSE: HAPPSTMNDS.BO)
EXPLEOSOL.BO vs HAPPSTMNDS.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, HAPPSTMNDS.BO has a market cap of 57.2B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while HAPPSTMNDS.BO trades at ₹376.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas HAPPSTMNDS.BO's P/E ratio is 25.19. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to HAPPSTMNDS.BO's ROE of +0.13%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to HAPPSTMNDS.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check HAPPSTMNDS.BO's competition here
ASM Technologies Limited (BSE: ASMTEC.BO)
EXPLEOSOL.BO vs ASMTEC.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, ASMTEC.BO has a market cap of 55.8B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while ASMTEC.BO trades at ₹4,849.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas ASMTEC.BO's P/E ratio is 298.84. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to ASMTEC.BO's ROE of +0.23%. Regarding short-term risk, EXPLEOSOL.BO is less volatile compared to ASMTEC.BO. This indicates lower risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check ASMTEC.BO's competition here
Datamatics Global Services Limited (BSE: DATAMATICS.BO)
EXPLEOSOL.BO vs DATAMATICS.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, DATAMATICS.BO has a market cap of 48.6B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while DATAMATICS.BO trades at ₹832.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas DATAMATICS.BO's P/E ratio is 25.02. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to DATAMATICS.BO's ROE of +0.13%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to DATAMATICS.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check DATAMATICS.BO's competition here
Datamatics Global Services Limited (NSE: DATAMATICS.NS)
EXPLEOSOL.BO vs DATAMATICS.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, DATAMATICS.NS has a market cap of 48.6B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while DATAMATICS.NS trades at ₹832.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas DATAMATICS.NS's P/E ratio is 24.99. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to DATAMATICS.NS's ROE of +0.13%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to DATAMATICS.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check DATAMATICS.NS's competition here
Cigniti Technologies Limited (BSE: CIGNITITEC.BO)
EXPLEOSOL.BO vs CIGNITITEC.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, CIGNITITEC.BO has a market cap of 34.8B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while CIGNITITEC.BO trades at ₹1,265.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas CIGNITITEC.BO's P/E ratio is 17.96. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to CIGNITITEC.BO's ROE of +0.30%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to CIGNITITEC.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check CIGNITITEC.BO's competition here
Cigniti Technologies Limited (NSE: CIGNITITEC.NS)
EXPLEOSOL.BO vs CIGNITITEC.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, CIGNITITEC.NS has a market cap of 34.7B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while CIGNITITEC.NS trades at ₹1,260.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas CIGNITITEC.NS's P/E ratio is 17.91. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to CIGNITITEC.NS's ROE of +0.30%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to CIGNITITEC.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check CIGNITITEC.NS's competition here
R Systems International Limited (BSE: RSYSTEMS.BO)
EXPLEOSOL.BO vs RSYSTEMS.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, RSYSTEMS.BO has a market cap of 31.3B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while RSYSTEMS.BO trades at ₹262.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas RSYSTEMS.BO's P/E ratio is 31.13. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to RSYSTEMS.BO's ROE of +0.26%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to RSYSTEMS.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check RSYSTEMS.BO's competition here
R Systems International Limited (NSE: RSYSTEMS.NS)
EXPLEOSOL.BO vs RSYSTEMS.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, RSYSTEMS.NS has a market cap of 31.2B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while RSYSTEMS.NS trades at ₹262.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas RSYSTEMS.NS's P/E ratio is 15.12. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to RSYSTEMS.NS's ROE of +0.26%. Regarding short-term risk, EXPLEOSOL.BO is less volatile compared to RSYSTEMS.NS. This indicates lower risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check RSYSTEMS.NS's competition here
RPSG Ventures Limited (NSE: RPSGVENT.NS)
EXPLEOSOL.BO vs RPSGVENT.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, RPSGVENT.NS has a market cap of 30.6B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while RPSGVENT.NS trades at ₹935.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas RPSGVENT.NS's P/E ratio is -22.16. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to RPSGVENT.NS's ROE of -0.04%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to RPSGVENT.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check RPSGVENT.NS's competition here
RPSG Ventures Limited (BSE: RPSGVENT.BO)
EXPLEOSOL.BO vs RPSGVENT.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, RPSGVENT.BO has a market cap of 30.6B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while RPSGVENT.BO trades at ₹934.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas RPSGVENT.BO's P/E ratio is -77.31. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to RPSGVENT.BO's ROE of -0.04%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to RPSGVENT.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check RPSGVENT.BO's competition here
Sasken Technologies Limited (NSE: SASKEN.NS)
EXPLEOSOL.BO vs SASKEN.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, SASKEN.NS has a market cap of 26.5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while SASKEN.NS trades at ₹1,811.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas SASKEN.NS's P/E ratio is 49.08. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to SASKEN.NS's ROE of +0.07%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to SASKEN.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check SASKEN.NS's competition here
Sasken Technologies Limited (BSE: SASKEN.BO)
EXPLEOSOL.BO vs SASKEN.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, SASKEN.BO has a market cap of 26.5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while SASKEN.BO trades at ₹1,812.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas SASKEN.BO's P/E ratio is 49.11. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to SASKEN.BO's ROE of +0.07%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to SASKEN.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check SASKEN.BO's competition here
Protean eGov Technologies Limi (BSE: PROTEAN.BO)
EXPLEOSOL.BO vs PROTEAN.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, PROTEAN.BO has a market cap of 25.2B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while PROTEAN.BO trades at ₹616.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas PROTEAN.BO's P/E ratio is 23.04. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to PROTEAN.BO's ROE of +0.10%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to PROTEAN.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check PROTEAN.BO's competition here
Protean eGov Technologies Ltd. (NSE: PROTEAN.NS)
EXPLEOSOL.BO vs PROTEAN.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, PROTEAN.NS has a market cap of 25.2B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while PROTEAN.NS trades at ₹616.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas PROTEAN.NS's P/E ratio is 29.45. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to PROTEAN.NS's ROE of +0.10%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to PROTEAN.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check PROTEAN.NS's competition here
Saksoft Limited (NSE: SAKSOFT.NS)
EXPLEOSOL.BO vs SAKSOFT.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, SAKSOFT.NS has a market cap of 21.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while SAKSOFT.NS trades at ₹169.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas SAKSOFT.NS's P/E ratio is 16.06. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to SAKSOFT.NS's ROE of +0.19%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to SAKSOFT.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check SAKSOFT.NS's competition here
Saksoft Limited (BSE: SAKSOFT.BO)
EXPLEOSOL.BO vs SAKSOFT.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, SAKSOFT.BO has a market cap of 21.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while SAKSOFT.BO trades at ₹169.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas SAKSOFT.BO's P/E ratio is 16.06. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to SAKSOFT.BO's ROE of +0.19%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to SAKSOFT.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check SAKSOFT.BO's competition here
Magellanic Cloud Ltd. (BSE: MCLOUD.BO)
EXPLEOSOL.BO vs MCLOUD.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, MCLOUD.BO has a market cap of 17.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while MCLOUD.BO trades at ₹29.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas MCLOUD.BO's P/E ratio is 10.05. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to MCLOUD.BO's ROE of +0.19%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to MCLOUD.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check MCLOUD.BO's competition here
Magellanic Cloud Ltd. (NSE: MCLOUD.NS)
EXPLEOSOL.BO vs MCLOUD.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, MCLOUD.NS has a market cap of 17.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while MCLOUD.NS trades at ₹29.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas MCLOUD.NS's P/E ratio is 16.81. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to MCLOUD.NS's ROE of +0.19%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to MCLOUD.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check MCLOUD.NS's competition here
Accelya Solutions India Limited (NSE: ACCELYA.NS)
EXPLEOSOL.BO vs ACCELYA.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, ACCELYA.NS has a market cap of 17.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while ACCELYA.NS trades at ₹1,142.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas ACCELYA.NS's P/E ratio is 17.25. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to ACCELYA.NS's ROE of +0.37%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to ACCELYA.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check ACCELYA.NS's competition here
Accelya Solutions India Limited (BSE: ACCELYA.BO)
EXPLEOSOL.BO vs ACCELYA.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, ACCELYA.BO has a market cap of 17.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while ACCELYA.BO trades at ₹1,142.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas ACCELYA.BO's P/E ratio is 17.23. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to ACCELYA.BO's ROE of +0.37%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to ACCELYA.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check ACCELYA.BO's competition here
Aurum PropTech Limited (BSE: AURUM.BO)
EXPLEOSOL.BO vs AURUM.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, AURUM.BO has a market cap of 16.6B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while AURUM.BO trades at ₹219.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas AURUM.BO's P/E ratio is -135.49. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to AURUM.BO's ROE of +0.03%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to AURUM.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check AURUM.BO's competition here
Aurum PropTech Limited (NSE: AURUM.NS)
EXPLEOSOL.BO vs AURUM.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, AURUM.NS has a market cap of 16.5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while AURUM.NS trades at ₹219.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas AURUM.NS's P/E ratio is -149.37. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to AURUM.NS's ROE of +0.03%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to AURUM.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check AURUM.NS's competition here
Media Matrix Worldwide Limited (BSE: MMWL.BO)
EXPLEOSOL.BO vs MMWL.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, MMWL.BO has a market cap of 16.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while MMWL.BO trades at ₹14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas MMWL.BO's P/E ratio is 1239.13. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to MMWL.BO's ROE of +0.05%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to MMWL.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check MMWL.BO's competition here
NINtec Systems Limited (BSE: NINSYS.BO)
EXPLEOSOL.BO vs NINSYS.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, NINSYS.BO has a market cap of 15.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while NINSYS.BO trades at ₹789.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas NINSYS.BO's P/E ratio is 48.68. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to NINSYS.BO's ROE of +0.42%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to NINSYS.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check NINSYS.BO's competition here
Dynacons Systems & Solutions Limited (BSE: DSSL.BO)
EXPLEOSOL.BO vs DSSL.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, DSSL.BO has a market cap of 15.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while DSSL.BO trades at ₹1,232.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas DSSL.BO's P/E ratio is 18.15. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to DSSL.BO's ROE of +0.31%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to DSSL.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check DSSL.BO's competition here
Dynacons Systems & Solutions Limited (NSE: DSSL.NS)
EXPLEOSOL.BO vs DSSL.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, DSSL.NS has a market cap of 15.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while DSSL.NS trades at ₹1,233.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas DSSL.NS's P/E ratio is 18.14. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to DSSL.NS's ROE of +0.31%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to DSSL.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check DSSL.NS's competition here
NINtec Systems Ltd (NSE: NINSYS.NS)
EXPLEOSOL.BO vs NINSYS.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, NINSYS.NS has a market cap of 15.3B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while NINSYS.NS trades at ₹782.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas NINSYS.NS's P/E ratio is 47.81. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to NINSYS.NS's ROE of +0.42%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to NINSYS.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check NINSYS.NS's competition here
Expleo Solutions Limited (NSE: EXPLEOSOL.NS)
EXPLEOSOL.BO vs EXPLEOSOL.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, EXPLEOSOL.NS has a market cap of 14.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while EXPLEOSOL.NS trades at ₹802.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas EXPLEOSOL.NS's P/E ratio is 11.93. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to EXPLEOSOL.NS's ROE of +0.17%. Regarding short-term risk, EXPLEOSOL.BO is less volatile compared to EXPLEOSOL.NS. This indicates lower risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check EXPLEOSOL.NS's competition here
Orient Technologies Ltd. (NSE: ORIENTTECH.NS)
EXPLEOSOL.BO vs ORIENTTECH.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, ORIENTTECH.NS has a market cap of 12.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while ORIENTTECH.NS trades at ₹261.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas ORIENTTECH.NS's P/E ratio is 273.07. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to ORIENTTECH.NS's ROE of +0.01%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to ORIENTTECH.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check ORIENTTECH.NS's competition here
3i Infotech Limited (BSE: 3IINFOTECH.BO)
EXPLEOSOL.BO vs 3IINFOTECH.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, 3IINFOTECH.BO has a market cap of 9.3B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while 3IINFOTECH.BO trades at ₹54.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas 3IINFOTECH.BO's P/E ratio is 111.67. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to 3IINFOTECH.BO's ROE of +0.02%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to 3IINFOTECH.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check 3IINFOTECH.BO's competition here
Xchanging Solutions Limited (BSE: XCHANGING.BO)
EXPLEOSOL.BO vs XCHANGING.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, XCHANGING.BO has a market cap of 7.5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while XCHANGING.BO trades at ₹66.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas XCHANGING.BO's P/E ratio is 12.55. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to XCHANGING.BO's ROE of +0.16%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to XCHANGING.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check XCHANGING.BO's competition here
Xchanging Solutions Limited (NSE: XCHANGING.NS)
EXPLEOSOL.BO vs XCHANGING.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, XCHANGING.NS has a market cap of 7.5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while XCHANGING.NS trades at ₹66.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas XCHANGING.NS's P/E ratio is 12.56. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to XCHANGING.NS's ROE of +0.16%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to XCHANGING.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check XCHANGING.NS's competition here
PVP Ventures Limited (NSE: PVP.NS)
EXPLEOSOL.BO vs PVP.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, PVP.NS has a market cap of 7.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while PVP.NS trades at ₹26.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas PVP.NS's P/E ratio is -103.37. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to PVP.NS's ROE of -0.03%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to PVP.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check PVP.NS's competition here
PVP Ventures Limited (BSE: PVP.BO)
EXPLEOSOL.BO vs PVP.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, PVP.BO has a market cap of 7.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while PVP.BO trades at ₹26.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas PVP.BO's P/E ratio is -84.03. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to PVP.BO's ROE of -0.03%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to PVP.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check PVP.BO's competition here
Vakrangee Limited (NSE: VAKRANGEE.NS)
EXPLEOSOL.BO vs VAKRANGEE.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, VAKRANGEE.NS has a market cap of 6.5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while VAKRANGEE.NS trades at ₹5.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas VAKRANGEE.NS's P/E ratio is 56.71. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to VAKRANGEE.NS's ROE of +0.05%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to VAKRANGEE.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check VAKRANGEE.NS's competition here
Vakrangee Limited (BSE: VAKRANGEE.BO)
EXPLEOSOL.BO vs VAKRANGEE.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, VAKRANGEE.BO has a market cap of 6.5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while VAKRANGEE.BO trades at ₹5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas VAKRANGEE.BO's P/E ratio is 56.71. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to VAKRANGEE.BO's ROE of +0.05%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to VAKRANGEE.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check VAKRANGEE.BO's competition here
Onward Technologies Limited (NSE: ONWARDTEC.NS)
EXPLEOSOL.BO vs ONWARDTEC.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, ONWARDTEC.NS has a market cap of 6.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while ONWARDTEC.NS trades at ₹292.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas ONWARDTEC.NS's P/E ratio is 14.97. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to ONWARDTEC.NS's ROE of +0.18%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to ONWARDTEC.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check ONWARDTEC.NS's competition here
Allied Digital Services Limited (NSE: ADSL.NS)
EXPLEOSOL.BO vs ADSL.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, ADSL.NS has a market cap of 6.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while ADSL.NS trades at ₹114.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas ADSL.NS's P/E ratio is 16.58. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to ADSL.NS's ROE of +0.06%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to ADSL.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check ADSL.NS's competition here
Allied Digital Services Limited (BSE: ADSL.BO)
EXPLEOSOL.BO vs ADSL.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, ADSL.BO has a market cap of 6.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while ADSL.BO trades at ₹114.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas ADSL.BO's P/E ratio is 16.58. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to ADSL.BO's ROE of +0.06%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to ADSL.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check ADSL.BO's competition here
Onward Technologies Limited (BSE: ONWARDTEC.BO)
EXPLEOSOL.BO vs ONWARDTEC.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, ONWARDTEC.BO has a market cap of 6.4B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while ONWARDTEC.BO trades at ₹292.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas ONWARDTEC.BO's P/E ratio is 15.66. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to ONWARDTEC.BO's ROE of +0.18%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to ONWARDTEC.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check ONWARDTEC.BO's competition here
Mindteck (India) Limited (NSE: MINDTECK.NS)
EXPLEOSOL.BO vs MINDTECK.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, MINDTECK.NS has a market cap of 6.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while MINDTECK.NS trades at ₹193.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas MINDTECK.NS's P/E ratio is 19.47. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to MINDTECK.NS's ROE of +0.11%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to MINDTECK.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check MINDTECK.NS's competition here
Mindteck (India) Limited (BSE: MINDTECK.BO)
EXPLEOSOL.BO vs MINDTECK.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, MINDTECK.BO has a market cap of 6.1B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while MINDTECK.BO trades at ₹195.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas MINDTECK.BO's P/E ratio is 19.45. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to MINDTECK.BO's ROE of +0.11%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to MINDTECK.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check MINDTECK.BO's competition here
Silver Touch Technologies Limited (NSE: SILVERTUC.NS)
EXPLEOSOL.BO vs SILVERTUC.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, SILVERTUC.NS has a market cap of 5.2B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while SILVERTUC.NS trades at ₹201.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas SILVERTUC.NS's P/E ratio is 20.87. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to SILVERTUC.NS's ROE of +0.24%. Regarding short-term risk, EXPLEOSOL.BO is less volatile compared to SILVERTUC.NS. This indicates lower risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check SILVERTUC.NS's competition here
Silver Touch Technologies Limited (BSE: SILVERTUC.BO)
EXPLEOSOL.BO vs SILVERTUC.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, SILVERTUC.BO has a market cap of 5.2B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while SILVERTUC.BO trades at ₹202.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas SILVERTUC.BO's P/E ratio is 20.86. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to SILVERTUC.BO's ROE of +0.24%. Regarding short-term risk, EXPLEOSOL.BO is less volatile compared to SILVERTUC.BO. This indicates lower risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check SILVERTUC.BO's competition here
Sigma Solve Limited (NSE: SIGMA.NS)
EXPLEOSOL.BO vs SIGMA.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, SIGMA.NS has a market cap of 5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while SIGMA.NS trades at ₹54.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas SIGMA.NS's P/E ratio is 5.71. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to SIGMA.NS's ROE of +0.38%. Regarding short-term risk, EXPLEOSOL.BO is less volatile compared to SIGMA.NS. This indicates lower risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check SIGMA.NS's competition here
Sigma Solve Limited (BSE: SIGMA.BO)
EXPLEOSOL.BO vs SIGMA.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, SIGMA.BO has a market cap of 5B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while SIGMA.BO trades at ₹55.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas SIGMA.BO's P/E ratio is 20.88. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to SIGMA.BO's ROE of +0.38%. Regarding short-term risk, EXPLEOSOL.BO is less volatile compared to SIGMA.BO. This indicates lower risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check SIGMA.BO's competition here
Tera Software Limited (BSE: TERASOFT.BO)
EXPLEOSOL.BO vs TERASOFT.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, TERASOFT.BO has a market cap of 4.8B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while TERASOFT.BO trades at ₹379.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas TERASOFT.BO's P/E ratio is 19.38. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to TERASOFT.BO's ROE of +0.19%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to TERASOFT.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check TERASOFT.BO's competition here
Tera Software Limited (NSE: TERASOFT.NS)
EXPLEOSOL.BO vs TERASOFT.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, TERASOFT.NS has a market cap of 4.8B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while TERASOFT.NS trades at ₹376.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas TERASOFT.NS's P/E ratio is 19.17. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to TERASOFT.NS's ROE of +0.19%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to TERASOFT.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check TERASOFT.NS's competition here
3i Infotech Limited (NSE: 3IINFOLTD.NS)
EXPLEOSOL.BO vs 3IINFOLTD.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, 3IINFOLTD.NS has a market cap of 4.7B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while 3IINFOLTD.NS trades at ₹23.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas 3IINFOLTD.NS's P/E ratio is 11.83. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to 3IINFOLTD.NS's ROE of +0.10%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to 3IINFOLTD.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check 3IINFOLTD.NS's competition here
3i Infotech Ltd. (BSE: 3IINFOLTD.BO)
EXPLEOSOL.BO vs 3IINFOLTD.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, 3IINFOLTD.BO has a market cap of 4.7B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while 3IINFOLTD.BO trades at ₹23.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas 3IINFOLTD.BO's P/E ratio is -2.54. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to 3IINFOLTD.BO's ROE of +0.10%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to 3IINFOLTD.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check 3IINFOLTD.BO's competition here
XTGlobal Infotech Ltd. (BSE: XTGLOBAL.BO)
EXPLEOSOL.BO vs XTGLOBAL.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, XTGLOBAL.BO has a market cap of 4.3B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while XTGLOBAL.BO trades at ₹33.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas XTGLOBAL.BO's P/E ratio is 45.06. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to XTGLOBAL.BO's ROE of +0.07%. Regarding short-term risk, EXPLEOSOL.BO is less volatile compared to XTGLOBAL.BO. This indicates lower risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check XTGLOBAL.BO's competition here
DiGiSPICE Technologies Limited (NSE: DIGISPICE.NS)
EXPLEOSOL.BO vs DIGISPICE.NS Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, DIGISPICE.NS has a market cap of 4.3B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while DIGISPICE.NS trades at ₹18.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas DIGISPICE.NS's P/E ratio is -10.42. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to DIGISPICE.NS's ROE of +0.08%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to DIGISPICE.NS. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check DIGISPICE.NS's competition here
CyberTech Systems and Software Limited (BSE: CYBERTECH.BO)
EXPLEOSOL.BO vs CYBERTECH.BO Comparison July 2026
Expleo Solutions Limited (BSE: EXPLEOSOL.BO) plays a significant role within the Technology sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXPLEOSOL.BO stands at 14.1B. In comparison, CYBERTECH.BO has a market cap of 4.2B. Regarding current trading prices, EXPLEOSOL.BO is priced at ₹801.85 on the BSE, while CYBERTECH.BO trades at ₹139.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXPLEOSOL.BO currently has a P/E ratio of 11.59, whereas CYBERTECH.BO's P/E ratio is 14.31. In terms of profitability, EXPLEOSOL.BO's ROE is +0.17%, compared to CYBERTECH.BO's ROE of +0.15%. Regarding short-term risk, EXPLEOSOL.BO is more volatile compared to CYBERTECH.BO. This indicates higher risk in terms of short-term price fluctuations for EXPLEOSOL.BO.Check CYBERTECH.BO's competition here